NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 19 filers reported holding NOVABAY PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,000 | -77.8% | 13,924 | -51.9% | 0.00% | – |
| Q2 2015 | $18,000 | +100.0% | 28,959 | +117.3% | 0.00% | – |
| Q1 2015 | $9,000 | -40.0% | 13,328 | -44.0% | 0.00% | – |
| Q4 2014 | $15,000 | -77.9% | 23,794 | -72.4% | 0.00% | -100.0% |
| Q2 2014 | $68,000 | +88.9% | 86,175 | +309.4% | 0.00% | – |
| Q3 2013 | $36,000 | – | 21,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 147,000 | $123,000 | 0.12% |
| Orbitronix, LP | 200,000 | $168,000 | 0.10% |
| WEDBUSH SECURITIES INC | 303,276 | $255,000 | 0.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 34,679 | $29,000 | 0.01% |
| GLENMEDE TRUST CO NA | 300,000 | $252,000 | 0.00% |
| BOSTON FAMILY OFFICE LLC | 17,500 | $15,000 | 0.00% |
| RONALD BLUE & CO LLC | 12,000 | $10,000 | 0.00% |
| NORTHERN TRUST CORP | 58,978 | $50,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 62,023 | $52,000 | 0.00% |
| UBS AG | 7,420 | $6,000 | 0.00% |